Advertisement

Advertisement

JP:4565 Stock Latest News

Nxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration

Company AnnouncementsNxera Pharma Secures Third AbbVie Milestone in Neurology Collaboration

Nxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program

PremiumCompany Announcements

Nxera Pharma Issues New Shares to Fund Japan Employee Stock Plan and Expand RSU Program

15d ago

Nxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch

PremiumCompany Announcements

Nxera Wins Taiwan Approval for QUVIVIQ Insomnia Drug, Eyes 2026 Launch

16d ago

Nxera Wins US$22.5m Milestone as Neurocrine Starts Phase 2 Schizophrenia Trial

PremiumCompany Announcements

Nxera Wins US$22.5m Milestone as Neurocrine Starts Phase 2 Schizophrenia Trial

17d ago

Nxera Pharma Hits Second Milestone in Lilly Metabolic Disease Partnership

PremiumCompany Announcements

Nxera Pharma Hits Second Milestone in Lilly Metabolic Disease Partnership

21d ago

Lilly’s Centessa Deal Highlights Nxera Pharma’s GPCR Platform Strength

PremiumCompany AnnouncementsLilly’s Centessa Deal Highlights Nxera Pharma’s GPCR Platform Strength

29d ago

Nxera Pharma Refreshes Board While Maintaining Core Leadership Team

Company Announcements

Nxera Pharma Refreshes Board While Maintaining Core Leadership Team

1M ago

Nxera Pharma Secures $3 Million Milestone Payment from Centessa

Company Announcements

Nxera Pharma Secures $3 Million Milestone Payment from Centessa

2M ago

Nxera Pharma Files for South Korean Approval of Insomnia Drug Daridorexant

PremiumCompany Announcements

Nxera Pharma Files for South Korean Approval of Insomnia Drug Daridorexant

2M ago

Sosei Group Earnings Call Marks Cautious Transition

PremiumCompany Announcements

Sosei Group Earnings Call Marks Cautious Transition

2M ago

Nxera Pharma Revamps Board to Strengthen Governance and Growth Strategy

PremiumCompany Announcements

Nxera Pharma Revamps Board to Strengthen Governance and Growth Strategy

3M ago

Nxera Pharma tightens focus as Japan and APAC portfolio powers 2025 growth

PremiumCompany Announcements

Nxera Pharma tightens focus as Japan and APAC portfolio powers 2025 growth

3M ago

Nxera Pharma Slashes Executive Bonuses Following 2025 Results

PremiumCompany AnnouncementsNxera Pharma Slashes Executive Bonuses Following 2025 Results

3M ago

Nxera Pharma boosts Japan-APAC portfolio and pipeline as 2025 restructuring sharpens growth focus

Company Announcements

Nxera Pharma boosts Japan-APAC portfolio and pipeline as 2025 restructuring sharpens growth focus

3M ago

Nxera Pharma Slashes Executive Bonuses After FY2025 Results to Sharpen Capital Discipline

Company Announcements

Nxera Pharma Slashes Executive Bonuses After FY2025 Results to Sharpen Capital Discipline

3M ago

Nxera Pharma Grows Revenue but Widens Loss on R&D and Finance Costs in 2025

PremiumCompany Announcements

Nxera Pharma Grows Revenue but Widens Loss on R&D and Finance Costs in 2025

3M ago

Nxera Pharma books ¥24.3bn non-cash impairment with no impact on consolidated results

PremiumCompany Announcements

Nxera Pharma books ¥24.3bn non-cash impairment with no impact on consolidated results

3M ago

Nxera Pharma Swings to Deeper FY2025 Loss but Guides for Strong Profit Rebound in 2026

PremiumCompany Announcements

Nxera Pharma Swings to Deeper FY2025 Loss but Guides for Strong Profit Rebound in 2026

3M ago

Nxera Pharma to Book $1.8 Million Milestone from Centessa Collaboration

PremiumCompany Announcements

Nxera Pharma to Book $1.8 Million Milestone from Centessa Collaboration

3M ago

Nxera Pharma spins out GPCR program to new life sciences-backed company

PremiumCompany AnnouncementsNxera Pharma spins out GPCR program to new life sciences-backed company

3M ago

Nxera Pharma’s Insomnia Drug Daridorexant Clears Key Phase 3 Hurdle in South Korea

Company Announcements

Nxera Pharma’s Insomnia Drug Daridorexant Clears Key Phase 3 Hurdle in South Korea

3M ago

Nxera Pharma Secures US$3.6 Million Milestone from Centessa Collaboration

Company Announcements

Nxera Pharma Secures US$3.6 Million Milestone from Centessa Collaboration

4M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >